Csenge Advisory Group Reduces Stake in Abbott Laboratories (

Csenge Advisory Group lowered its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 6.6% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 15,631 shares of the healthcare product maker’s stock after selling 1,099 shares during the period. […]

Related Keywords

Canada , Danielj Starks , Andreaf Wainer , , Altshuler Shaham Ltd , Investment Management , Abbott Laboratories Company Profile , Securities Exchange Commission , Halpern Financial Inc , Morgan Stanley , Citigroup , Csenge Advisory Group , Royal Bank , Exchange Commission , Cornerstone Planning Group , Financial Services , Abbott Laboratories , Free Report , Advisory Group , Shaham Ltd , Planning Group , Director Daniel , Get Free Report , Established Pharmaceutical Products , Diagnostic Products , Nutritional Products , Abbott Laboratories Daily , Nyse Abt , Abt , Medical , 00282410 , Sec Filings , 13f , Hedge Fund Holdings , Institutional Investor Holdings ,